Clinical Trial: MPV as a Predictor for ACS in Patients With MASLD

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07487571) titled 'MPV as a Predictor for ACS in Patients With MASLD' on March 17.

Brief Summary: The aim of this study is to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Sohag University Hospital.

Study Start Date: March 05

Study Type: OBSERVATIONAL

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease Acute Coronary Syndromes (ACS)

Recruitment...